Literature DB >> 29286046

Neuropsychiatric disorders: Side effects of olanzapine worsened by metabolic dysfunction.

Ivone Leong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29286046     DOI： 10.1038/nrendo.2017.183

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  1 in total

1.  Obesity exacerbates the acute metabolic side effects of olanzapine.

Authors:  Logan K Townsend; Willem T Peppler; Natasha D Bush; David C Wright
Journal:  Psychoneuroendocrinology       Date:  2017-12-08       Impact factor: 4.905
  1 in total
  2 in total

1.  STING activation in alveolar macrophages and group 2 innate lymphoid cells suppresses IL-33-driven type 2 immunopathology.

Authors:  Li She; Gema D Barrera; Liping Yan; Hamad H Alanazi; Edward G Brooks; Peter H Dube; Yilun Sun; Hong Zan; Daniel P Chupp; Nu Zhang; Xin Zhang; Yong Liu; Xiao-Dong Li
Journal:  JCI Insight       Date:  2021-02-08

Review 2.  Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature.

Authors:  Giulia M Giordano; Francesco Brando; Pasquale Pezzella; Maria De Angelis; Armida Mucci; Silvana Galderisi
Journal:  Front Psychiatry       Date:  2022-08-30       Impact factor: 5.435
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.